MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0324222

Медицинская библиотека · PloS one · 2025

Effects of risperidone on amino acid metabolism, glucose, and kidney function in healthy adults: A pilot randomized controlled trial.

Oshima Megumi, Toyama Tadashi, Nakade Yusuke, Miyagi Sakae, Ogura Hisayuki, Nakagawa Shiori, Yuasa Takahiro, Koshino Akihiko, Horikoshi Keisuke, Minami Taichiro, Sako Keisuke, Tsuge Shunsuke, Tamai Akira, Nishioka Ryo, Miyagawa Taro, Ito Kiyoaki, Kitajima Shinji, Mizushima Ichiro, Hara Akinori, Sakai Norihiko, Shimizu Miho, Tokumaru Toshiaki, Tsubomoto Makoto, Kikuchi Mitsuru, Kinoshita Masashi, Nakada Mitsutoshi, Mita Masashi, Iwata Yasunori, Wada Takashi

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

d-serine administration prevents kidney damage in murine models of acute kidney injury, and risperidone inhibits the activity of d-amino acid oxidase, which regulate plasma d-amino acid levels. This pilot randomized controlled trial investigated the effects of risperidone on glucose, amino acid metabolism, and kidney function in healthy adults. Healthy adults with a homeostasis model assessment of insulin resistance (HOMA-IR) of ≥ 1.6 and estimated glomerular filtration rate (eGFR) of ≥ 60 mL/min/1.73m2 were randomly assigned to the risperidone and control groups. The risperidone group received 0.5 mg/day risperidone for 4 days. The primary outcome was mean change in HOMA-IR on day 5, and the secondary outcomes were changes in d-amino acid levels, eGFR, and urinary albumin. Seven participants were randomized to the risperidone and control groups. The changes in HOMA-IR, eGFR, and urinary albumin on day 5 were not significantly different between the two groups (all p > 0.05). Mean changes in plasma d-serine level and urinary d-serine/creatinine ratio were significantly higher in the risperidone group than in the control group (0.2 vs. -0.3 nmol/mL, p = 0.03 and 38.2 vs. -25.8 nmol/mL, p = 0.01, respectively). Short-term risperidone affects d-serine metabolism without instigating acute adverse effects on kidney or glucose homeostasis in healthy individuals. Clinical Trial Registry number: This study was registered with the Japan Registry for Clinical Trials (jRCTs041210165).

Для цитирования: Oshima Megumi, Toyama Tadashi, Nakade Yusuke, Miyagi Sakae, Ogura Hisayuki, Nakagawa Shiori, Yuasa Takahiro, Koshino Akihiko, Horikoshi Keisuke, Minami Taichiro, Sako Keisuke, Tsuge Shunsuke, Tamai Akira, Nishioka Ryo, Miyagawa Taro, Ito Kiyoaki, Kitajima Shinji, Mizushima Ichiro, Hara Akinori, Sakai Norihiko, Shimizu Miho, Tokumaru Toshiaki, Tsubomoto Makoto, Kikuchi Mitsuru, Kinoshita Masashi, Nakada Mitsutoshi, Mita Masashi, Iwata Yasunori, Wada Takashi. Effects of risperidone on amino acid metabolism, glucose, and kidney function in healthy adults: A pilot randomized controlled trial.. PloS one. 2025. DOI: 10.1371/journal.pone.0324222.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.